Subjective well-being and ability to work after SARS-CoV-2 immunization with the vector vaccine ChAdOx1-S (AstraZeneca COVID-19 vaccine) Results of an anonymous survey

Kalbhenn, J; Gabler, F; Heinrich, S; Steinmann, D

Kalbhenn, J (通讯作者)，Univ Klinikum Freiburg, Klin Anasthesiol & Intens Med, Hugstetter Str 55, D-79106 Freiburg, Germany.

ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2022; 72 (2): 51

Abstract

Background The SARS coronavirus 19 vaccine ChAdOx1-S (Vaxzevria, AstraZeneca) has been licensed since January 2021 by the Paul Ehrlich Institute for G......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索